Celanese Corp — Form 8-K
Filed November 2, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 48/100
What the filing says
Celanese reported Q3 2026 adjusted EPS of $1.65 (23% YoY growth) and free cash flow of $461M. The company raised full-year 2026 FCF guidance from prior range to $750–800M and announced the pending sale of an additional 19% stake in Nutrinova JV to Mitsui for ~$152M (closing expected Q4 2026). Engineered Materials adjusted EBIT was $209M (5% YoY growth; 9% excluding Micromax divestiture); Acetyl Chain adjusted EBIT was $236M (25%+ YoY growth). Net debt-to-EBITDA improved to 4.9x; company expects to reach ~4.7x by YE 2026. Management guided FY2026 adjusted EPS of $6.00–$6.25.
Why this rating
Strong operational execution, raised FCF guidance, and M&A proceeds support deleveraging. Relative to $6B market cap, improved trajectory is meaningful but execution-dependent and macro-sensitive.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.